Medical technology presents a new ethical question in the case of a patient with a left ventricular assist device who, when informed that he has pneumonia and is ineligible for a heart transplant, asks that the LVAD be turned off.
Clinical trials for the blood substitute PolyHeme exposed the possibility for ambiguous interpretation of the FDA’s waiver of informed consent for emergency research.
Medical technology presents a new ethical question in the case of a patient with a left ventricular assist device who, when informed that he has pneumonia and is ineligible for a heart transplant, asks that the LVAD be turned off.
Physicians and surrogates should take patients' preferences into account in making clinical intervention decisions, even if the patients have been found to lack decision-making capacity.
Physicians and surrogates should take patients' preferences into account in making clinical intervention decisions, even if the patients have been found to lack decision-making capacity.
Physicians and surrogates should take patients' preferences into account in making clinical intervention decisions, even if the patients have been found to lack decision-making capacity.
A landmark court case in California determined that a competent adult patient has the right to forgo medical treatment and the patient's autonomy supersedes the state's interest in preserving the patient's life.